Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

63.25p
   
  • Change Today:
      3.25p
  • 52 Week High: 82.50p
  • 52 Week Low: 27.50p
  • Currency: UK Pounds
  • Shares Issued: 436.45m
  • Volume: 1,336,875
  • Market Cap: £276.05m
  • RiskGrade: 461
  • Beta: 0.78

Latest ShareCast News

Avacta upbeat on fresh data from second oncology asset

By Josh White

Date: Thursday 18 Dec 2025

(Sharecast News) - Avacta reported new pharmacology data on its second oncology asset, FAP-Exd (AVA6103), on Thursday, showing sustained tumor exposure and prolonged responses across multiple preclinical models, as the company prepared to begin phase one testing in the first quarter of 2026.

Avacta reports 'clinically meaningful' tumour shrinkage in AVA6000 trial

By Josh White

Date: Wednesday 17 Dec 2025

(Sharecast News) - Avacta Therapeutics said on Wednesday that new data from the phase 1b cohort of its ongoing trial of faridoxorubicin, also known as AVA6000, showed clinically meaningful tumour shrinkage in patients with salivary gland cancer, reinforcing results previously reported from the phase 1a stage of the study.

Avacta presents promising findings to Boston conference

By Benjamin Chiou

Date: Monday 27 Oct 2025

(Sharecast News) - Shares in Avacta rose on Monday after the clinical stage biopharmaceutical company presented preclinical data showing its novel dual payload pre|CISION technology at a oncology conference in Boston.

Avacta raises £16m, releases solid clinical tria... 20-Oct-2025 ShareCast
Avacta reports continued progress in second quar... 02-Jul-2025 ShareCast
Avacta posts narrower full-year losses from cont... 06-Jun-2025 ShareCast
Avacta pushes back annual results due to auditor... 27-May-2025 ShareCast
Avacta agrees to sell UK-based diagnostics unit 07-Mar-2025 ShareCast
Avacta reports promising results from ongoing cl... 16-Jan-2025 ShareCast
Peel Hunt starts Avacta at 'buy' with 99p price ... 21-Nov-2024 ShareCast
Avacta Group appoints new non-executive chair 20-Jun-2024 ShareCast
Avacta reports further progress in chemotherapy ... 23-May-2024 ShareCast
Avacta reaches milestone in AVA6000 dose escalat... 21-Mar-2024 ShareCast
Avacta tumbles after raising £25.7m in heavily d... 29-Feb-2024 ShareCast
Avacta appoints new head of research and develop... 19-Jan-2024 ShareCast
Avacta appoints new chief business officer 19-Dec-2023 ShareCast
Avacta hails "encouraging" clinical data from ca... 13-Dec-2023 ShareCast
Avacta reports higher losses in first half 28-Sep-2023 ShareCast
Avacta brings in clinical consultant as it hunts... 20-Sep-2023 ShareCast
Avacta upbeat on fresh data from chemotherapy tr... 19-Sep-2023 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 63.25p
Change Today 3.25p
% Change 5.42 %
52 Week High 82.50p
52 Week Low 27.50p
Volume 1,336,875
Shares Issued 436.45m
Market Cap £276.05m
Beta 0.78
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average
Price Trend
37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average
Income Not Available
Growth
40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average
58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 06-Jan-2026

Time Volume / Share Price
13:11 399 @ 61.83p
13:04 3,020 @ 61.75p
13:04 6,372 @ 62.69p
13:03 140 @ 62.70p
12:54 1,420 @ 61.55p

Avacta Group Key Personnel

CEO Christina Coughlin

Top of Page